Rideshare Can Remove Barrier to Colorectal Cancer Screening
If given a way to get home from a colonoscopy after sedation, many patients will seek out a procedure they would otherwise avoid.
Read MorePosted by Melanie Hamilton-Basich | Jun 14, 2023 | Colorectal |
If given a way to get home from a colonoscopy after sedation, many patients will seek out a procedure they would otherwise avoid.
Read MorePosted by Melanie Hamilton-Basich | Jun 13, 2023 | Cancer, Molecular Diagnostics |
Pfizer and Thermo Fisher Scientific Inc. have entered into a collaboration agreement to help increase local access to next-generation sequencing-based testing for lung and breast cancer patients.
Read MorePosted by Melanie Hamilton-Basich | Jun 7, 2023 | Cancer |
The analysis showed strong performance of Grail’s MCED methylation-based platform in the symptomatic population of more than 6,000 patients
Read MorePosted by Melanie Hamilton-Basich | Jun 6, 2023 | Cancer, Sequencing Systems |
The study’s multi-cancer early detection data show Exai’s RNA- and AI-based platform can detect multiple cancer types at the earliest stages using a single, standard blood sample.
Read MorePosted by Chris Wolski | Jun 1, 2023 | Cancer |
Labcorp has launched Labcorp Plasma Focus, a new liquid biopsy test enabling targeted therapy selection for solid tumors.
Read More